Related Experiment Video

Updated: May 11, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Multidrug-resistant organisms in dialysis patients

David P Calfee1

  • 1Department of Medicine and Public Health, Weill Cornell Medical College, New York, NY, USA. dpc9003@med.cornell.edu

Seminars in Dialysis
|May 1, 2013
PubMed

Insights

Multidrug-resistant organisms (MDROs) cause serious healthcare-associated infections (HAIs), especially in dialysis patients. Consistent implementation of infection control practices is crucial but often lacking, necessitating improved strategies for MDRO prevention.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Healthcare Epidemiology

Background:

  • Multidrug-resistant organisms (MDROs) are a growing threat, causing significant morbidity and mortality through healthcare-associated infections (HAIs).
  • Dialysis patients are disproportionately vulnerable to MDROs, exhibiting higher colonization and infection rates compared to other healthcare-exposed populations.

Purpose of the Study:

  • To highlight the critical need for enhanced infection control in dialysis facilities.
  • To underscore the gap between recommended practices and their consistent implementation.
  • To advocate for further research and improved strategies for MDRO prevention in vulnerable patient groups.

Main Methods:

  • Review of current literature and data on MDRO prevalence in healthcare settings.
  • Analysis of the effectiveness of existing infection control recommendations.
  • Identification of barriers to consistent implementation of infection control practices.

Main Results:

  • Recommended infection control practices have the potential to significantly reduce MDRO transmission and infections.
  • Current data indicate inconsistent adherence to these vital infection control measures in healthcare settings.
  • Dialysis patients face a heightened risk due to frequent healthcare exposure.

Conclusions:

  • Consistent implementation of infection control practices is essential for preventing MDROs in dialysis patients.
  • Further research is needed to develop novel, effective, and cost-efficient MDRO prevention strategies.
  • Increased healthcare worker awareness and adherence are critical for optimizing patient safety and care quality.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...